These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 7912298)
1. Hepatic expression of hepatocyte-growth-factor-like/macrophage-stimulating protein mRNA in fulminant hepatic failure. Harrison P; Degen SJ; Williams R; Farzaneh F Lancet; 1994 Jul; 344(8914):27-9. PubMed ID: 7912298 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure. Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963 [TBL] [Abstract][Full Text] [Related]
4. Differential screening of a human chromosome 3 library identifies hepatocyte growth factor-like/macrophage-stimulating protein and its receptor in injured lung. Possible implications for neuroendocrine cell survival. Willett CG; Smith DI; Shridhar V; Wang MH; Emanuel RL; Patidar K; Graham SA; Zhang F; Hatch V; Sugarbaker DJ; Sunday ME J Clin Invest; 1997 Jun; 99(12):2979-91. PubMed ID: 9185522 [TBL] [Abstract][Full Text] [Related]
5. Loss and recovery of liver regeneration in rats with fulminant hepatic failure. Eguchi S; Lilja H; Hewitt WR; Middleton Y; Demetriou AA; Rozga J J Surg Res; 1997 Oct; 72(2):112-22. PubMed ID: 9356231 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure. Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Miyazaki H; Sugihara J; Tomita E; Muto Y Hepatology; 1989 Jun; 9(6):875-81. PubMed ID: 2523850 [TBL] [Abstract][Full Text] [Related]
7. Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. Bezerra JA; Carrick TL; Degen JL; Witte D; Degen SJ J Clin Invest; 1998 Mar; 101(5):1175-83. PubMed ID: 9486989 [TBL] [Abstract][Full Text] [Related]
8. Increased expression of mRNA for hepatocyte growth factor-like protein during liver regeneration and inflammation. Bezerra JA; Laney DW; Degen SJ Biochem Biophys Res Commun; 1994 Aug; 203(1):666-73. PubMed ID: 8074719 [TBL] [Abstract][Full Text] [Related]
9. Hepatic catabolism of intravenously administered pro-macrophage-stimulating protein in mice. Leonard EJ; Skeel A J Leukoc Biol; 1996 Oct; 60(4):453-8. PubMed ID: 8864128 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats. Cowin AJ; Kallincos N; Hatzirodos N; Robertson JG; Pickering KJ; Couper J; Belford DA Cell Tissue Res; 2001 Nov; 306(2):239-50. PubMed ID: 11702235 [TBL] [Abstract][Full Text] [Related]
11. Cis-acting elements in the hepatocyte growth factor-like protein gene regulate kidney and liver-specific expression in mice. Wetzel CC; Degen SJ; Waltz SE DNA Cell Biol; 2003 May; 22(5):293-301. PubMed ID: 12941157 [TBL] [Abstract][Full Text] [Related]
12. Structure of the human D1F15S1A locus: a chromosome 1 locus with 97% identity to the chromosome 3 gene coding for hepatocyte growth factor-like protein. Degen SJ; McDowell SA; Waltz SE; Gould F; Stuart LA; Carritt B DNA Seq; 1998; 8(6):409-13. PubMed ID: 10728827 [TBL] [Abstract][Full Text] [Related]
13. Biological aspects of macrophage-stimulating protein (MSP) and its receptor. Leonard EJ Ciba Found Symp; 1997; 212():183-91; discussion 192-7. PubMed ID: 9524771 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor and plasminogen activation in fulminant hepatic failure. Pernambuco JR; Hughes RD; Langley PG; Izumi S; Williams R Blood Coagul Fibrinolysis; 1994 Aug; 5(4):511-5. PubMed ID: 7841306 [TBL] [Abstract][Full Text] [Related]
15. Human hepatocyte growth factor in blood of patients with fulminant hepatic failure. I. Clinical aspects. Tsubouchi H; Hirono S; Gohda E; Nakayama H; Takahashi K; Sakiyama O; Kimoto M; Kawakami S; Miyoshi H; Kubozono O Dig Dis Sci; 1991 Jun; 36(6):780-4. PubMed ID: 1827761 [TBL] [Abstract][Full Text] [Related]
16. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors. Suh KS; Lilja H; Kamohara Y; Eguchi S; Arkadopoulos N; Neuman T; Demetriou AA; Rozga J J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325 [TBL] [Abstract][Full Text] [Related]
17. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure. Hughes RD; Zhang L; Tsubouchi H; Daikuhara Y; Williams R J Hepatol; 1994 Jan; 20(1):106-11. PubMed ID: 8201209 [TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor/hepatopoietin A is expressed in fat-storing cells from rat liver but not myofibroblast-like cells derived from fat-storing cells. Schirmacher P; Geerts A; Pietrangelo A; Dienes HP; Rogler CE Hepatology; 1992 Jan; 15(1):5-11. PubMed ID: 1530788 [TBL] [Abstract][Full Text] [Related]
20. Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Kawashima R; Mochida S; Matsui A; YouLuTuZ Y; Ishikawa K; Toshima K; Yamanobe F; Inao M; Ikeda H; Ohno A; Nagoshi S; Uede T; Fujiwara K Biochem Biophys Res Commun; 1999 Mar; 256(3):527-31. PubMed ID: 10080931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]